Autres langues Destiny Pharma plc

Actions

DEST

GB00BDHSP575

Marché Fermé - London S.E. Autres places de cotation 17:35:15 24/04/2024			Varia. 5j.	Varia. 1 janv.
21,5 ^GBX	-2,27 %		+17,81 %	-69,29 %

31/01	RÉSULTATS ET TRANSACTIONS : STV augmente sa participation dans Two Cities Television	AN
31/01	Destiny Pharma fait progresser ses thérapies contre les infections cutanées et les infections du côlon après des évaluations positives	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

EARNINGS AND TRADING: STV raises holding in Two Cities Television	31/01
Destiny Pharma to Advance Skin, Colon Infection Therapies After Positive Evaluations	31/01
Destiny Pharma plc Announces Clinical Development Update Positive Results from XF-73 Dermal Safety Study	31/01
Destiny Pharma seeks to capitalise on XF-73 market potential in 2024	04/01
Destiny Pharma Says Talks Ongoing with Potential Partners for Nasal Asset	04/01
Destiny Pharma celebrates study findings on "potent" flagship drug	17/10/23
AIM WINNERS & LOSERS: Destiny Pharma posts "landmark" XF-73 data	17/10/23
Destiny Pharma plc Announces the Publication of New Microbiological Data on Xf-73 (Exeporfinium Chloride), Its Leading Antibacterial Drug,In Frontiers in Cellular and Infection Microbiology	17/10/23
Dianomi swings to loss; Epwin revenue up	20/09/23
Destiny Pharma : Interim results for the six months ended 30 June 2023	20/09/23
Earnings Flash (DEST.L) DESTINY PHARMA Reports H1 Loss GBX-3.10	20/09/23
Destiny Pharma plc Reports Earnings Results for the Half Year Ended June 30, 2023	20/09/23
MGC Pharmaceuticals granted psilocybin import permit	31/07/23
Destiny Pharma plc Announces the Publication of New Data in the Journal Infection & Drug Resistance from A Study Evaluating the Pfficacy of Xf-73	31/07/23
FTSE 100 Closes Tuesday Up 0.2% Lifted by Unilever, Miners	25/07/23
Destiny Pharma says former Chair Nigel Rudd return to role	25/07/23
Former Destiny Pharma Chairman Reprises Role	25/07/23
Destiny Pharma plc Appoints Sir Nigel Rudd as New Chairman	25/07/23
FTSE 100 Rose 1.8% Led by Housebuilders on Signs of Slowing UK Inflation	19/07/23
UK Corporate Credit Distress Likely to Rise	19/07/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Destiny Pharma plc

Actions

DEST

GB00BDHSP575

Autres langues

Filtres